Venetoclax: Will It Be Approved for 11Q Deletion Patients? Could venetoclax be used soon for patients with 11q deletion? Dr. Nicole Lamanna of Columbia University Medical Center, answers a viewer’s question in this “Ask the Expert” segment. Venetoclax (Venclexta) is currently approved for 17p deletion according to Dr. Lamanna, “It’s coming” for additional groups of patients. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |